Thyrotoxicosis is a well-documented and studied complication of treatment with amiodarone, but little has been written about the risks and treatment of recurrent thyrotoxicosis upon re-exposure to amiodarone. One such case is outlined here and discussed by a panel of experts.
|Original language||English (US)|
|Number of pages||5|
|State||Published - Feb 1 2004|
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism